Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

GSK (GSK) reached the main goal in a Phase 3 trial for its RSV shot, Arexvy co--administered with Shingles vaccine Shingrix.

The trial testing the immune response of co-administration of GSK's blockbuster vaccines, Shingrix and Arexvy, in adults over ...

GSK’s attempt to develop the first vaccine for herpes simplex virus (HSV) has ended in failure, leaving the race open for the ...

Herpes zoster (HZ) is a painful disease resulting ... ratio of €9513/quality-adjusted life year was achieved with HZ vaccination in the 70–79 years age group in France. Scenario analysis ...

Here's what to know about the latest vaccines, who needs them and how they help prevent the more serious effects of COVID-19. The FDA granted emergency use authorization last week to an updated ...

Have you gotten the shingles vaccination? What about the flu vax? If so, I have good news and more good news for you...and your brain. Of the many factors that contribute to healthy aging ...

Sept 3 (Reuters) - Vaxcyte's (PCVX.O), opens new tab shares surged as much as 48% to a record high on Tuesday after the company said its experimental pneumococcal vaccine showed promising results ...

As updated coronavirus vaccines hit U.S. pharmacy shelves, adults without health insurance are discovering the shots are no longer free, instead costing up to $200. The federal Bridge Access ...

Officials hope to vaccinate more than 640,000 children under age 10. A mass polio vaccination campaign is underway in Gaza to inoculate children after the first case in 25 years was recently ...